Olfactory dysfunction at six months after coronavirus disease 2019 infection

被引:12
|
作者
Leedman, S. R. [1 ]
Sheeraz, M. [2 ]
Sanfilippo, P. G. [3 ]
Edgar, D. W. [4 ,5 ,6 ]
D'Aulerio, G., V [5 ]
Robb, D. M. [5 ]
Richards, T. [5 ]
Blyth, C. C. [5 ]
Mackey, D. A. [5 ,7 ]
机构
[1] Sir Charles Gairdner Hosp, Dept Otolaryngol Head & Neck Surg, Hosp Ave, Nedlands, WA 6009, Australia
[2] Fiona Stanley Hosp, COVID 19 Res Response, Murdoch, WA, Australia
[3] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Australia
[4] Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA, Australia
[5] Univ Western Australia, Fac Hlth & Med Sci, Perth, WA, Australia
[6] Fiona Stanley Hosp, Physiotherapy Dept, Murdoch, WA, Australia
[7] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA, Australia
来源
JOURNAL OF LARYNGOLOGY AND OTOLOGY | 2021年 / 135卷 / 09期
关键词
Coronavirus; COVID-19; Anosmia; Hyposmia; Olfactory Impairment; POPULATION; SMELL;
D O I
10.1017/S0022215121002085
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective This study aimed to assess olfactory dysfunction in patients at six months after confirmed coronavirus disease 2019 infection. Methods Coronavirus disease 2019 positive patients were assessed six months following diagnosis. Patient data were recoded as part of the adapted International Severe Acute Respiratory and Emerging Infection Consortium Protocol. Olfactory dysfunction was assessed using the University of Pennsylvania Smell Identification Test. Results Fifty-six patients were included. At six months after coronavirus disease 2019 diagnosis, 64.3 per cent of patients (n = 36) were normosmic, 28.6 per cent (n = 16) had mild to moderate microsmia and 7 per cent (n = 4) had severe microsmia or anosmia. There was a statistically significant association between older age and olfactory dysfunction. Hospital or intensive care unit admission did not lead to worse olfactory outcomes compared to those managed in the out-patient setting. Conclusion At six months after coronavirus disease 2019 diagnosis, approximately two-thirds of patients will be normosmic. This study is the first to describe six-month outcomes for post-coronavirus disease 2019 patients in terms of olfactory dysfunction.
引用
收藏
页码:839 / 843
页数:5
相关论文
共 50 条
  • [21] Subclinical myocardial dysfunction in patients following coronavirus disease 2019 infection
    Saeed, Sahrai
    Rajani, Ronak
    JOURNAL OF CLINICAL ULTRASOUND, 2022, 50 (01) : 25 - 27
  • [22] Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review
    Chung, Tom Wai-Hin
    Sridhar, Siddharth
    Zhang, Anna Jinxia
    Chan, Kwok-Hung
    Li, Hang-Long
    Wong, Fergus Kai-Chuen
    Ng, Ming-Yen
    Tsang, Raymond King-Yin
    Lee, Andrew Chak-Yiu
    Fan, Zhimeng
    Ho, Ronnie Siu-Lun
    Luk, Shiobhon Yiu
    Kan, Wai-Kuen
    Lam, Sonia Hiu-Yin
    Wu, Alan Ka-Lun
    Leung, Sau-Man
    Chan, Wai-Ming
    Ng, Pauline Yeung
    To, Kelvin Kai-Wang
    Cheng, Vincent Chi-Chung
    Lung, Kwok-Cheung
    Hung, Ivan Fan-Ngai
    Yuen, Kwok-Yung
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (06):
  • [23] Impact of olfactory dysfunction on quality of life in coronavirus disease 2019 patients: a systematic review
    Saniasiaya, J.
    Prepageran, N.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2021, 135 (11): : 947 - 952
  • [24] Discriminatory Value of Self-reported Olfactory Dysfunction in the Prediction of Coronavirus Disease 2019
    Akaishi, Tetsuya
    Kushimoto, Shigeki
    Katori, Yukio
    Kure, Shigeo
    Igarashi, Kaoru
    Fujita, Motoo
    Takayama, Shin
    Abe, Michiaki
    Kikuchi, Akiko
    Tanaka, Junichi
    Abe, Yoshiko
    Imai, Hiroyuki
    Inaba, Yohei
    Iwamatsu-Kobayashi, Yoko
    Nishioka, Takashi
    Onodera, Ko
    Ishii, Tadashi
    INTERNAL MEDICINE, 2021, 60 (18) : 2905 - 2910
  • [25] Olfactory Hallucinations in the Context of Coronavirus Disease 2019
    Kumar, Parul
    Lynch, Sean
    Shahar, Sivan
    Klepacz, Lidia
    Ferrando, Stephen J.
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2021, 62 (05): : 553 - 554
  • [26] Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection
    Yao, Lin
    Wang, Guo-Lin
    Shen, Yuan
    Wang, Zhuang-Ye
    Zhan, Bing-Dong
    Duan, Li-Jun
    Lu, Bing
    Shi, Chao
    Gao, Yu-Meng
    Peng, Hong-Hong
    Wang, Guo-Qiang
    Wang, Dong-Mei
    Jiang, Ming-Dong
    Cao, Guo-Ping
    Ma, Mai-Juan
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (04): : 586 - 594
  • [27] Acute Macular Neuroretinopathy after Coronavirus Disease 2019 Infection
    Fang, Lijian
    Tian, Tong
    Zhuang, Suoqing
    Feng, Yu
    Wang, Lei
    Wu, Lili
    Wang, Fei
    Zhou, Chunyuan
    Chen, Chunjie
    Zhang, Tie
    Zhang, Sihan
    Xue, Lili
    Wei, Wenbin
    OPHTHALMOLOGY RETINA, 2024, 8 (04): : 409 - 414
  • [28] Gastrointestinal Sequelae 3 and 6 Months After Hospitalization for Coronavirus Disease 2019
    Rizvi, Anam
    Patel, Zankhesh
    Liu, Yan
    Satapathy, Sanjaya K.
    Sultan, Keith
    Trindade, Arvind J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (11) : 2438 - +
  • [29] Olfactory dysfunction amongst children and adolescents with laboratory confirmed coronavirus disease 2019: a systematic review
    Saniasiaya, J.
    Kulasegarah, J.
    Narayanan, P.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2021, 135 (11): : 953 - 957
  • [30] Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
    Miyakawa, Kei
    Kubo, Sousuke
    Jeremiah, Sundararaj Stanleyraj
    Go, Hirofumi
    Yamaoka, Yutaro
    Ohtake, Norihisa
    Kato, Hideaki
    Ikeda, Satoshi
    Mihara, Takahiro
    Matsuba, Ikuro
    Sanno, Naoko
    Miyakawa, Masaaki
    Shinkai, Masaharu
    Miyazaki, Tomoyuki
    Ogura, Takashi
    Ito, Shuichi
    Kaneko, Takeshi
    Yamamoto, Kouji
    Goto, Atsushi
    Ryo, Akihide
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (02):